These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39030509)

  • 21. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
    Walsh T; Macey R; Kerr AR; Lingen MW; Ogden GR; Warnakulasuriya S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD010276. PubMed ID: 34282854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
    Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
    BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
    Dahlstrom KR; Anderson KS; Guo M; Kwon MC; Messick CA; Pettaway CA; Asomaning N; Hopper M; Price A; Xu L; Day AT; Gillenwater AM; Sturgis EM
    Oral Oncol; 2021 Sep; 120():105397. PubMed ID: 34182223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.
    Lassig AAD; Joseph AM; Lindgren BR; Yueh B
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):670-678. PubMed ID: 28418447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
    St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
    Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal cytology in oropharyngeal brushings and in oral rinses is not associated with HPV infection: The OHMAR study.
    Benevolo M; Rollo F; Giuliani M; Pichi B; Latini A; Pellini R; Vescio MF; Morrone A; Cristaudo A; Donà MG
    Cancer Cytopathol; 2020 Sep; 128(9):648-655. PubMed ID: 32485093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings.
    Nunes DN; Kowalski LP; Simpson AJ
    Oral Oncol; 2000 Nov; 36(6):525-8. PubMed ID: 11036246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of elevated serum CD44 levels in patients with oral squamous cell carcinoma.
    Sawant S; Ahire C; Dongre H; Joshi S; Jamghare S; Rane P; Kane S; Chaukar D
    J Oral Pathol Med; 2018 Aug; 47(7):665-673. PubMed ID: 29752852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the CD44 isoform v-6 (sCD44var, v6) in the saliva of patients with laryngeal carcinoma and its prognostic role.
    Trapasso S; Garozzo A; Belfiore A; Allegra E
    Cancer Biomark; 2016; 16(2):275-80. PubMed ID: 26756618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the sociodemographic characteristics and efficacy of screening for oral, head and neck potential malignant lesions in apparently healthy adults in Jos Nigeria.
    Adoga AA; Silas OA; Yaro JP; Okwori ET; Iduh AA; Mgbachi CJ
    Indian J Cancer; 2016; 53(2):252-255. PubMed ID: 28071621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults.
    Walsh T; Liu JL; Brocklehurst P; Glenny AM; Lingen M; Kerr AR; Ogden G; Warnakulasuriya S; Scully C
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD010173. PubMed ID: 24258195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
    Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive Diagnostic Techniques for Oral and Oropharyngeal Cancer Discovery.
    Huber MA
    Dent Clin North Am; 2018 Jan; 62(1):59-75. PubMed ID: 29126494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma.
    Carinci F; Stabellini G; Calvitti M; Pelucchi S; Targa L; Farina A; Pezzetti F; Pastore A
    J Craniofac Surg; 2002 Jan; 13(1):85-9. PubMed ID: 11887001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
    Elmahgoub F
    Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
    Macey R; Walsh T; Brocklehurst P; Kerr AR; Liu JL; Lingen MW; Ogden GR; Warnakulasuriya S; Scully C
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010276. PubMed ID: 26021841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.